Package 50268-758-12

{"route": ["ORAL"], "spl_id": "47fc8e5e-ba97-0118-e063-6394a90ad45c", "openfda": {"unii": ["OTT9J7900I"], "rxcui": ["349251"], "spl_set_id": ["a215f64c-84de-0649-e053-2a95a90a9d59"], "manufacturer_name": ["AvPAK"]}, "finished": true, "packaging": [{"sample": false, "description": "20 BLISTER PACK in 1 BOX (50268-758-12)  / 1 TABLET in 1 BLISTER PACK (50268-758-11)", "package_ndc": "50268-758-12", "marketing_start_date": "20200330"}], "brand_name": "TENOFOVIR DISOPROXIL FUMARATE", "product_id": "50268-758_47fc8e5e-ba97-0118-e063-6394a90ad45c", "dosage_form": "TABLET", "pharm_class": ["Hepatitis B Virus Nucleoside Analog Reverse Transcriptase Inhibitor [EPC]", "Human Immunodeficiency Virus Nucleoside Analog Reverse Transcriptase Inhibitor [EPC]", "Nucleoside Reverse Transcriptase Inhibitors [MoA]", "Nucleosides [CS]"], "product_ndc": "50268-758", "generic_name": "tenofovir disoproxil fumarate", "labeler_name": "AvPAK", "product_type": "HUMAN PRESCRIPTION DRUG", "brand_name_base": "TENOFOVIR DISOPROXIL FUMARATE", "active_ingredients": [{"name": "TENOFOVIR DISOPROXIL FUMARATE", "strength": "300 mg/1"}], "application_number": "ANDA090742", "marketing_category": "ANDA", "marketing_start_date": "20200330", "listing_expiration_date": "20271231"}